California Stem Cell Agency Pledges to Do "Everything" to Salvage Cure for Bubble Baby Disease

Orchard Therapeutics Says, However, It Will Continue to Deprioritize the Therapy and Has Already Saved $2.5 Million

The California stem cell agency today said it was doing “everything” it can to move forward on a gene therapy that has saved the lives of more than 50 persons but which has been pushed aside by the company that has exclusive rights to it.

The matter involves Orchard Therapeutics PLC and a product called OTL-101, which is a curative treatment for what is …